Application Notes:
N-Glycinated glucosylsphingosine is an analogue of the important biomolecule glucosylsphingosine. It is ideal for
use as an internal standard in the extraction and mass spectrometry analysis of glucosylsphingosine from natural samples.(1)
The free amine group gives this product very similar physical characteristics to the natural glycolipid while the glycine adds
an additional 57 units to the molecule making it easy to detect by MS.
Glucosylceramide and glucosylsphingosine are important biological species that are the precursors for many
complex glycosphingolipids. These lipids are involved in critical cellular functions such as cellular proliferation,
differentiation, adhesion, signal transduction, cell-to-cell interactions, tumorigenesis, and metastasis. One of the most
important roles of glucosylsphingosine is as a biomarker for the lysosomal storage disorder Gaucher disease.
Gaucher disease is characterized by an accumulation of glucocerebroside due to a deficiency in the enzyme
glucocerebrosidase and it has now been found that glucosylsphingosine also accumulates in this disease.(2) This
accumulation of glucopsychosine contributes to neuronal dysfunction and destruction in patients with neuronopathic Gaucher
disease(3) and it has been found to be a potent inhibitor of glucocerebrosidase. At least some instances of Gaucher disease
also have a deficiency in the activity of glucosylsphingosine beta-glucosidase, the enzyme responsible for cleaving off the
glucose of glucopsychosine and glucocerebroside. Like glucocerebroside and galactocerebroside, glucosylsphingosine can
increase Ca2
+ mobilization from intracellular stores although it uses a different mechanism.(4)
References:
1. R. Krüger et al. Quantification of the Fabry marker lysoGb3 in human plasma by tandem mass spectrometry. Journal of Chromatography B., Vol. 883-884, pp. 128-135, 2012
2. E. Orvisky et al. “Glucosylsphingosine accumulation in tissues from patients with Gaucher disease: correlation with phenotype and genotype” Molecular genetics and metabolism, Vol. 76(4) pp. 262-270, 2002
3. R. Brady et al. “Toxicity of glucosylsphingosine (glucopsychosine) to cultured neuronal cells: a model system for assessing neuronal damage in Gaucher disease type 2 and 3” Neurobiology of Disease, Vol. 14(3) pp. 595-601, 2003
4. E. Loyd-Evans et al. “Glucosylceramide and Glucosylsphingosine Modulate Calcium Mobilization from Brain Microsomes via Different Mechanisms” The Journal of Biological Chemistry, Vol. 278 pp. 23594-23599, 2003